IGF2BP3 and non-small cell lung carcinoma: In this work, we found that circIGF2BP3, a circRNA derived from a back-splicing event between exons 4 and 13 of IGF2BP3, is markedly overexpressed and compromises antitumor immunity in NSCLC.